1. International Self Care Day – consumer empowerment drives the ‘new approach’ to health July 21, 2017 –   Consumer trends are driving a “new approach to health” where consumers take a more active role in the management of their health. The challenges to meet this demand for greater consumer empowerment will require a better use of […]

OTC proton pump inhibitors and the quality use of medicines 5 July, 2017 – The Australian Self Medication Industry (ASMI) has stated that consumers can have confidence in the safety profile and effectiveness of over-the counter (OTC) Proton Pump Inhibitors (PPIs) when they are used as recommended. OTC PPIs are used for the relief of frequent heartburn […]

1. World Self Medication Industry (WSMI) General Assembly, October 18-19, 2017 There is a need to prioritise self-care in national and global health policy, which will be a topic for discussion at the World Self Medication Industry (WSMI) General Assembly, October 18-19. This conference brings together leading international healthcare experts from several fields, including medical, pharmaceutical, […]

Combination medication provides innovative option for pain relief when taken as directed 8 June, 2017 – The Australian Self Medication Industry (ASMI) today reminded consumers that it is imperative to follow the instructions on the labels of all medications, and seek advice from a healthcare professional if anything is unclear to them. This follows the […]

New research has minimal implications for OTC painkillers when they are used according to label instructions May 10, 2017 – The Australian Self Medication Industry (ASMI) said today that most consumers who follow the on-pack instructions for over-the-counter (OTC) non-steroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen, naproxen and diclofenac, should not be concerned by reports […]

1.The time is right to examine access to medicines Great opportunity exists with next wave of regulatory reform 7 April 2017 – The Australian Self Medication Industry (ASMI) has commended the TGA for opening up discussions on ways to streamline, speed up and provide incentives for the process of down-scheduling medicines (‘switch’) so that consumers […]

1. OTC labels the key to safe use of NSAID painkillers 17 March, 2017 – The Australian Self Medication Industry acknowledges that a Danish study examining the use of non-steroidal anti-inflammatory drugs (NSAIDs) has further explored the association between NSAIDs and cardiovascular disease in people who are elderly, sick and using other medications. However, the […]

ASMI addresses 4 Corners concerns about advertising claims for complementary medicines 15 February, 2017 – The Australian Self Medication Industry (ASMI) today addressed concerns raised in a 4 Corners report on complementary medicines that the huge growth of the complementary medicines markets and its move into the mainstream has resulted in some companies overreaching in […]

Three simple steps to better outcomes for consumers’ health and the economy 24 January 2017 The Australian Self Medication Industry (ASMI) has issued a trio of recommendations to the Federal Government outlining key mechanisms that will provide consumers with better access to information and medicines to self-manage their health, provide savings for the national healthcare […]